Recent developments in oncology continue to provide promise for patients. Investigators are actively exploring novel approaches, including harnessing the immune system, targeted agents, and personalized approaches. A key study published this week showcases the efficacy of a experimental drug in managing advanced NSCLC. Furthermore, ongoing studi⦠Read More